Medical Disorders
Basic InformationLookupsLatest News
Your Gas Stove Might Make You (and the Planet) SickShorter Life Spans for Elderly Living Downwind of Fracking Sites: StudyIn a First, a Robot Performs Laparoscopic Surgery on Pig Without Human Help2 Rheumatoid Arthritis Drugs Tied to Lower Risk of Parkinson'sBeyond Antibodies: Vaccines Teach Your Immune T-Cells to Fight COVID Long TermRehab or Steroid Shots: What's Best for Arthritic Knees?Pre-Op Treatment May Be Advance Against Deadly Liver CancersMonths After Moderna Booster, Antibodies Decline Faster With OmicronHospital Defends Decision to Deny Heart Transplant to Unvaccinated ManScientists Regrow Frog's Lost Leg: Could Human Amputees Someday Do the Same?Almost 1 in 10 U.S. Lung Transplants Now Due to COVIDAny Change to Menstrual Cycle After COVID Vaccine Is Minor, Temporary: StudiesModerna Begins Testing Booster Shot Aimed at OmicronNewer Rheumatoid Arthritis Drug Might Raise Heart, Cancer RisksScientists Watch, Worry About New 'Stealth' Version of Omicron VariantCommon Gout Drug Is Safe in Patients With Kidney IssuesScientists Discover How the 'Mono' Virus Might Trigger MSSaline IV Drip Just as Good as Pricier Options in Hospital ICUs: StudyCOVID Infection Unlikely From Hospital Surfaces: StudyMany People With Asthma Have Mixed Feelings About Masks: PollMore Proof That COVID Vaccines Won't Harm FertilityMore Than 1 Million U.S. Kids Diagnosed With COVID in Single WeekBiden Administration Withdraws Vaccine Mandate for Large EmployersSurvivors of Severe COVID Face Higher Odds for Another Hospitalization Soon AfterOmicron Batters Already Strained U.S. Hospitals3 Factors Helped Teens Stay Mentally Healthy During PandemicVaccination Key to 'Super Immunity' Against COVID-19Pandemic to Endemic: Is a New Normal Near?Pfizer Begins Testing a COVID Vaccine Targeted to Omicron3 Reasons Why Trying to Get COVID Is a Bad IdeaFree N95 Masks Begin Arriving in U.S. PharmaciesOmicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level OffFDA Limits Use of Two COVID Antibody TreatmentsCOVID Can Affect Brains of Hospitalized KidsCOVID Vaccine Hesitancy Falling Faster Among Black Americans Than WhitesEngland to Lift Travel Restrictions for Vaccinated VisitorsAre Pins or a Cast Better for a Broken Wrist?FDA May Limit Use of Two COVID Antibody TreatmentsSome Patients With Macular Degeneration Could Stop Monthly Eye InjectionsYou Don't Have to Smoke to Get Lung CancerCOVID Vaccine Won't Affect Fertility, But Getting COVID MightThree New Studies Confirm Power of Booster Shots Against OmicronHit Your Head? Look for These Warning Signs of ConcussionArthritis & the COVID Vaccine: What You Need to KnowCOVID Boosters Keep Older Americans Out of Hospitals: CDCCOVID Rapid Test Makers Struggling to Meet DemandAHA News: A Healthy Thyroid Can Be Key to a Healthy HeartAnother Study Finds Vaccine Booster 'Neutralizes' Omicron'Artificial Pancreas' Can Help Kids With Type 1 DiabetesGetting Back to Sports After Recovering from COVID-19
Questions and AnswersVideosLinksBook Reviews
Related Topics

Men's Health
Women's Health

Kroger, Walmart Hike Prices on COVID At-Home Tests

HealthDay News
by Cara Murez
Updated: Jan 5th 2022

new article illustration

WEDNESDAY, Jan. 5, 2022 (HealthDay News) -- Your at-home COVID-19 test could now come with a higher price tag, depending on where you buy it.

Kroger and Walmart stores were selling the test kits at cost or at a discount of up to 35% for 100 days after making a deal with the U.S. federal government, CBS News reported. That ended in mid-December, and now some retailers have raised the prices.

The at-home test kits already had higher prices at other retail chains that did not pledge to sell them at cost.

Walmart kept the lower price of $14 for a box of two tests for longer than agreed to until after the holidays, a company spokesperson told CBS MoneyWatch. It is now selling Abbott's Binax Now test kits for $19.88 online.

"We have seen significant demand for at-home COVID-19 testing kits and are working closely with our suppliers to meet this demand and get the needed product to our customers," the Walmart spokesperson said.

Meanwhile, a Kroger spokesperson said that the "pricing program has now phased out and retail pricing has been reinstated” after fulfilling its commitment to the Biden administration.

Kroger is now selling the Binax Now at-home COVID-19 test kit in its stores, pharmacies and online for $23.99. It is currently sold out online. The spokesperson said Kroger also sells Quidel's QuickVue test in its stores that don’t have pharmacies.

Walmart is also selling Intrivo Diagnostics’ On/Go rapid self-test kit and it is in stock at for $29.99 for a box of two kits. The test kits, made by health care company Ro, better known for its hair loss and erectile dysfunction products, were among its top three sellers over the holidays, Ro co-founder and CEO Zachariah Reitano told CBS MoneyWatch.

"Our patients kept asking for tests, and we partnered with the makers of the On/Go test to provide them," Reitano said. "They have been investing tremendously in manufacturing capacity even as cases have ebbed and flowed, in the potential case where there was a far more contagious variant that spread quickly."

Others retailers, like pharmacy chain CVS Health, have been selling the test kits for $23.99 a box all along, according to CBS MoneyWatch. That retailer is also currently sold out on the kits online.

Testing demand is high as the Omicron variant spreads rapidly around the country. The variant now comprises 95% of U.S. cases, according to an estimate from the U.S. Centers for Disease Control and Prevention.

The rapid test kits are nearly sold out everywhere online, according to, which tracks the availability of products. Pre-orders are available for some.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.



Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net